Related Experiment Video

Updated: Dec 31, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.8K

microRNA-1908-5p inhibits proliferation and promotes apoptosis by targeting PP5 in NSCLC

Yu Li1, Luoman Gan2, Wentao Li1

  • 1Department of Respiration, The Second Affiliated Hospital of Guangxi Medical University Nanning 530007, Guangxi, China.

International Journal of Clinical and Experimental Pathology
|January 15, 2020
PubMed

Insights

MicroRNA-1908-5p is downregulated in non-small cell lung cancer (NSCLC), inhibiting tumor growth. It targets Protein Phosphatase 5 (PP5), suggesting a therapeutic role for microRNA-1908-5p in NSCLC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-1908-5p plays a role in various cancers.
  • Its specific mechanism in non-small cell lung cancer (NSCLC) pathogenesis requires further elucidation.
  • Protein phosphatase 5 catalytic subunit (PP5) is a potential target of microRNA-1908-5p.

Purpose of the Study:

  • To investigate the role of microRNA-1908-5p in NSCLC.
  • To identify the molecular mechanism by which microRNA-1908-5p affects NSCLC.
  • To determine if PP5 is a direct target of microRNA-1908-5p.

Main Methods:

  • Real-time PCR to quantify microRNA-1908-5p expression in NSCLC tissues.
  • Bioinformatic prediction and Dual-luciferase assay to validate PP5 as a target.
  • Cellular assays (proliferation, apoptosis) and nude mouse xenograft models to assess functional effects.
  • Western blot to analyze protein expression.

Main Results:

  • MicroRNA-1908-5p expression was significantly lower in NSCLC tissues compared to adjacent tissues.
  • Lower microRNA-1908-5p expression correlated with metastatic potential and reduced patient survival.
  • PP5 was confirmed as a direct target of microRNA-1908-5p.
  • MicroRNA-1908-5p inhibited NSCLC cell proliferation and promoted apoptosis in vitro and in vivo.

Conclusions:

  • MicroRNA-1908-5p acts as a tumor suppressor in NSCLC.
  • The microRNA-1908-5p/PP5 axis regulates NSCLC pathogenesis.
  • MicroRNA-1908-5p warrants further investigation as a potential therapeutic agent for NSCLC.
Keywords:
MicroRNA-1908-5pNSCLCPP5prognosisproliferation

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.7K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K